Latest debt-to-equity ratio
Denali Therapeutics Debt-to-equity ratio
Direct answer
Denali Therapeutics's debt-to-equity ratio is 4.51%.
The verified market snapshot reports 4.51%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 30, 2026.
Get free Denali Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 4.51%
Explore related company data
View Denali Therapeutics's market capitalizationView Denali Therapeutics's price-to-book ratioView Denali Therapeutics's return on equityView Denali Therapeutics's 52-week price rangeView Denali Therapeutics's profit marginView all Denali Therapeutics key metricsReturn to Denali Therapeutics profile